CIMP and colon cancer gets more complicated

Gut

Volumn 56, Issue 11, 2007, Pages 1498-1500

  Grady, William M ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLOOXYGENASE 2 INHIBITOR; K RAS PROTEIN; PROTEIN P53;

ANEUPLOIDY; CHROMOSOMAL INSTABILITY; CHROMOSOME TRANSLOCATION; COLON CANCER; DIGESTIVE SYSTEM CANCER; GENE EXPRESSION; GENE MUTATION; HUMAN; METHYLATION; MICROSATELLITE INSTABILITY; NOTE; PHENOTYPE; PRIORITY JOURNAL;

COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; GENES, SUPPRESSOR; HUMANS;

EID: 35649014263     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.125732     Document Type: Note

References (33)

1. Grady WM. Genomic instability and colon cancer. Cancer Metastasis Rev 2004;23:11-27.
2. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-93.
3. Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
4. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-93.
5. Yamashita K, Dai T, Dai Y, et al. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 2003;4:121-31.
6. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004;20:63-8.
7. Waterland RA, Lin JR, Smith CA, et al. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet 2006;15:705-16.
8. Widschwendter M, Fiegl H, Egle D, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007;39:157-8.
9. Ohm JE, McGarvey KM, Yu X, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007;39:237-42.
10. Ogino S, Kawasaki T, Kirkner GJ, et al. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in CRC. Gut 2007;56:1564-71.
11. Colditz GA, Hankinson SE. The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer 2005;5:388-96.
12. Wei EK, Giovannucci E, Fuchs CS, et al. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005;97:1688-94.
13. Ogino S, Kawasaki T, Kirkner GJ, et al. Evaluation of markers for CpG Island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 2007;9:305-14.
14. Ogino S, Kawasaki T, Kirkner GJ, et al. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Mod Pathol 2007;20:15-22.
15. Ogino S, Kawasaki T, Ogawa A, et al. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Hum Pathol 2007;38:842-9.
16. Ogino S, Kawasaki T, Ogawa A, et al. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. Hum Pathol 2007;38:614-20.
17. Ogino S, Kawasaki T, Ogawa A, et al. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype. Hum Pathol 2007;38:585-92.
18. Ogino S, Meyerhardt JA, Kawasaki T, et al. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch 2007;450:529-37.
19. Ogino S, Kawasaki T, Kirkner GJ, et al. Downregulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol 2006;210:147-54.
20. Ogino S, Odze RD, Kawasaki T, et al. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol 2006;30:1175-83.
21. Goldstein NS. Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol 2006;125:146-53.
22. Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004;53:1137-44.
23. Jass JR. Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol 2004;2:1-8.
24. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Re 2004;23:29-39.
25. Yates PA, Burman RW, Mummaneni P, et al. Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation. J Biol Chem 1999;274:36357-61.
26. Kikuchi S, Yamada D, Fukami T, et al. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma. Cancer 2006;106:1751-8.
27. Vuillemenot BR, Hutt JA, Belinsky SA. Gene promoter hypermethylation in mouse lung tumors. Mol Cancer Res 2006;4:267-73.
28. Esteller M. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 2000;36:2294-300.
29. Whitehall V, Walsh M, Young J, et al. Methylation of O-6-methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001;61:827-30.
30. Shen L, Kondo Y, Rosner GL, et al. MGMT promoter methylation and field delect in sporadic colorectal cancer. J Natl Cancer Inst 2005;97:1330-8.
31. Ahuja N, Li Q, Mohan M, et al. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;58:5489-94.
32. Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006;12:989-95.
33. Rashid A, Shen L, Morris JS, et al. CpG island methylation in colorectal adenomas. Am J Pathol 2001;159:1129-35.